Evidence map›Paper›PMID 29016848›Full record

ArticleHuman molecular genetics2017

Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity.

Dai-Chi Liu, Joseph Seimetz, Kwan Young Lee, Auinash Kalsotra, Hee Jung Chung, Hua Lu, Nien-Pei Tsai

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Inhibition of intracellular proton-sensitive CaActa pharmaceutica Sinica. B · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Dai-Chi LiuDepartment of Molecular and Integrative Physiology, School of Molecular and Cellular Biology.
Joseph SeimetzDepartment of Biochemistry, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Kwan Young LeeDepartment of Molecular and Integrative Physiology, School of Molecular and Cellular Biology.
Auinash KalsotraDepartment of Biochemistry, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Hee Jung ChungDepartment of Molecular and Integrative Physiology, School of Molecular and Cellular Biology.
Hua LuDepartment of Biochemistry and Molecular Biology.
Nien-Pei TsaiDepartment of Molecular and Integrative Physiology, School of Molecular and Cellular Biology.
University of Illinois Urbana-Champaign · USLaboratoire d’immunologie intégrative du cancer · FRSociety for Neuroscience · USTulane University · US

Funding

Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
The Role of Ribosomal Proteins in the P53-MDM2 PathwayR01CA095441 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2002 to 2021
$5.1M
Post-transcriptional mechanisms of gene regulation in cardiac cell growth and developmentR01HL126845 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KALSOTRA, AUINASH · 2015 to 2023
$3.5M
Role of the AMPK-MDMX-p53 pathway in cancerR01CA127724 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2007 to 2019
$3.0M
Tuning neuronal excitability by axonal targeting of Kv7 channelsR01NS083402 · NINDS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHUNG, HEE JUNG · 2015 to 2019
$1.7M
Dual Targeting of the p53 pathway for development of anti-cancer therapyR01CA172468 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2012 to 2016
$1.5M
Targeting GRP78 for p53 activation as anti-cancer therapyR21CA190775 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2015 to 2016
$360k
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppressionR21CA201889 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2016 to 2017
$360k
NCI NIH HHS R01 CA095441NCI NIH HHS R01 CA127724NCI NIH HHS R01 CA172468NCI NIH HHS R21 CA190775NCI NIH HHS R21 CA201889NHLBI NIH HHS R01 HL126845NIGMS NIH HHS T32 GM070421NINDS NIH HHS R01 NS083402
6 · The paper itself

Abstract

Activating Group 1 (Gp1) metabotropic glutamate receptors (mGluRs), including mGluR1 and mGluR5, elicits translation-dependent neural plasticity mechanisms that are crucial to animal behavior and circuit development. Dysregulated Gp1 mGluR signaling has been observed in numerous neurological and psychiatric disorders. However, the molecular pathways underlying Gp1 mGluR-dependent plasticity mechanisms are complex and have been elusive. In this study, we identified a novel mechanism through which Gp1 mGluR mediates protein translation and neural plasticity. Using a multi-electrode array (MEA) recording system, we showed that activating Gp1 mGluR elevates neural network activity, as demonstrated by increased spontaneous spike frequency and burst activity. Importantly, we validated that elevating neural network activity requires protein translation and is dependent on fragile X mental retardation protein (FMRP), the protein that is deficient in the most common inherited form of mental retardation and autism, fragile X syndrome (FXS). In an effort to determine the mechanism by which FMRP mediates protein translation and neural network activity, we demonstrated that a ubiquitin E3 ligase, murine double minute-2 (Mdm2), is required for Gp1 mGluR-induced translation and neural network activity. Our data showed that Mdm2 acts as a translation suppressor, and FMRP is required for its ubiquitination and down-regulation upon Gp1 mGluR activation. These data revealed a novel mechanism by which Gp1 mGluR and FMRP mediate protein translation and neural network activity, potentially through de-repressing Mdm2. Our results also introduce an alternative way for understanding altered protein translation and brain circuit excitability associated with Gp1 mGluR in neurological diseases such as FXS.

Indexed as

AnimalsCell Culture TechniquesDown-RegulationFragile X Messenger Ribonucleoprotein 1HippocampusHumansMiceMice, KnockoutNerve NetNeuronsProto-Oncogene Proteins c-mdm2RabbitsReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateSignal TransductionFragile X Messenger Ribonucleoprotein 1metabotropic glutamate receptor type 1Proto-Oncogene Proteins c-mdm2Receptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID29016848
PMCPMC6075224
OpenAlexW2735850153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.